NFKB1 and metastatic neoplasm: Western blot results showed that diabetes resulted in significantly elevated TNF-α, IL-6 and p-NFκB expression in primary and metastatic tumors, while SB203580 treatment markedly reduced their expression (Figure 8E–8G).